Pharming Group N.V. (AMS:PHARM) Held Back By Insufficient Growth Even After Shares Climb 26%
Dec 21
Have your own idea? Try our Stock Screener
Dutch (AEX) Healthcare Sector Analysis
UpdatedDec 25, 2024
DataAggregated Company Financials
Companies5
- 7D2.8%
- 3M-11.0%
- 1Y12.9%
- YTD11.2%
Over the last 7 days, the Healthcare industry has dropped 1.3%, driven by Koninklijke Philips declining 1.5%. Over the past 12 months, the industry was up 11%. As for the next few years, earnings are expected to grow by 57% per annum.
Sector Valuation and Performance
Has the Dutch Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 25 Dec 2024 | €25.2b | €18.6b | -€608,756,675.13 | n/a | -41.5x | 1.4x |
| Fri, 22 Nov 2024 | €25.5b | €18.6b | -€608,385,681.05 | n/a | -41.9x | 1.4x |
| Sun, 20 Oct 2024 | €30.0b | €18.7b | -€597,487,320.45 | 58.4x | -50.3x | 1.6x |
| Tue, 17 Sep 2024 | €28.2b | €18.7b | -€610,649,449.41 | 56.9x | -46.2x | 1.5x |
| Thu, 15 Aug 2024 | €26.3b | €18.7b | -€609,326,437.44 | 46.3x | -43.1x | 1.4x |
| Sat, 13 Jul 2024 | €25.2b | €18.6b | -€848,569,273.57 | 53.7x | -29.7x | 1.4x |
| Mon, 10 Jun 2024 | €25.1b | €18.6b | -€847,847,717.78 | 53.3x | -29.6x | 1.3x |
| Wed, 08 May 2024 | €24.9b | €18.6b | -€846,731,208.97 | 58.5x | -29.4x | 1.3x |
| Fri, 05 Apr 2024 | €20.0b | €18.6b | -€569,438,745.39 | n/a | -35.1x | 1.1x |
| Sun, 03 Mar 2024 | €20.2b | €18.6b | -€575,986,222.28 | n/a | -35x | 1.1x |
| Tue, 30 Jan 2024 | €21.9b | €19.3b | -€878,413,081.00 | n/a | -24.9x | 1.1x |
| Thu, 28 Dec 2023 | €22.7b | €19.3b | -€876,600,359.00 | n/a | -25.9x | 1.2x |
| Sat, 25 Nov 2023 | €21.2b | €19.3b | -€876,969,695.00 | n/a | -24.2x | 1.1x |
| Mon, 23 Oct 2023 | €19.2b | €19.1b | -€2,302,323,952.00 | n/a | -8.3x | 1x |
| Wed, 20 Sep 2023 | €21.8b | €19.1b | -€2,424,112,150.00 | n/a | -9x | 1.1x |
| Fri, 18 Aug 2023 | €22.4b | €19.1b | -€2,427,883,732.00 | n/a | -9.2x | 1.2x |
| Sun, 16 Jul 2023 | €22.3b | €18.8b | -€2,534,571,295.00 | n/a | -8.8x | 1.2x |
| Tue, 13 Jun 2023 | €20.8b | €18.8b | -€2,533,958,225.00 | n/a | -8.2x | 1.1x |
| Thu, 11 May 2023 | €20.9b | €18.8b | -€2,517,864,929.00 | 62x | -8.3x | 1.1x |
| Sat, 08 Apr 2023 | €18.6b | €18.5b | -€2,026,698,216.00 | 57.8x | -9.2x | 1x |
| Mon, 06 Mar 2023 | €17.4b | €18.5b | -€2,016,543,721.00 | 26.2x | -8.6x | 0.9x |
| Wed, 01 Feb 2023 | €18.2b | €18.6b | -€1,793,981,173.00 | 253.7x | -10.1x | 1x |
| Fri, 30 Dec 2022 | €16.8b | €18.1b | -€1,534,757,345.00 | 258x | -10.9x | 0.9x |
| Sun, 27 Nov 2022 | €16.6b | €18.1b | -€1,539,397,107.00 | 245.3x | -10.8x | 0.9x |
| Tue, 25 Oct 2022 | €15.9b | €17.9b | €134.8m | 29.3x | 117.9x | 0.9x |
| Thu, 22 Sep 2022 | €19.7b | €17.9b | €230.6m | 37.1x | 85.6x | 1.1x |
| Sat, 20 Aug 2022 | €21.3b | €17.9b | €227.8m | 38.4x | 93.6x | 1.2x |
| Mon, 18 Jul 2022 | €23.2b | €18.0b | €261.5m | 41.1x | 88.5x | 1.3x |
| Wed, 15 Jun 2022 | €23.5b | €18.0b | €263.2m | 40.6x | 89.3x | 1.3x |
| Fri, 13 May 2022 | €25.7b | €18.0b | €266.5m | 36.3x | 96.5x | 1.4x |
| Sun, 10 Apr 2022 | €30.2b | €17.8b | €485.7m | 39.8x | 62.3x | 1.7x |
| Tue, 08 Mar 2022 | €28.0b | €17.8b | €490.1m | 31.8x | 57.1x | 1.6x |
| Thu, 03 Feb 2022 | €30.2b | €17.9b | €414.5m | 35.9x | 72.7x | 1.7x |
| Sat, 01 Jan 2022 | €32.3b | €20.4b | €979.5m | 25.7x | 32.9x | 1.6x |
Price to Earnings Ratio
32.9x
Current Industry PE
- Investors are relatively neutral on the Dutch Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 1.2x.
Past Earnings Growth
- Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 3.0% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the Dutch Healthcare sector?
| NL Market | -1.64% | |
| Healthcare | 2.79% | |
| Biotech | 3.16% | |
| Medical Equipment | 2.77% | |
| Healthcare Services | 0% | |
| Healthtech | 0% | |
| Life Sciences | 0% | |
| Pharma | -6.70% | |
Industry PE
Forecasted Growth
- Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 63% over the next 5 years.
- In contrast, the Biotech industry is expected to see its earnings growth to stay flat over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PHIA Koninklijke Philips | €24.49 | 2.8% +€616.5m | 20.5% | PS1.3x | |
| PHARM Pharming Group | €0.89 | 7.9% +€44.4m | -14.2% | PS2.2x | |
| GLPG Galapagos | €25.92 | 1.6% +€27.7m | -28.7% | PS6.6x | |
| VVY Vivoryon Therapeutics | €1.97 | 0.5% +€260.7k | -76.1% | PB3.7x |